Ryman Healthcare (RYM) Stock Statistics & Valuation Metrics
Total Valuation
Ryman Healthcare has a market cap or net worth of AUD 1.43B. The enterprise value is AUD 3.73B.
- Market Cap
- AUD 1.43B
- Enterprise Value
- AUD 3.73B
Share Statistics
Ryman Healthcare has 1,015,745,360 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 1,015,745,360
- Owned by Insiders
- ―
- Owned by Institutions
- 8.26%
Financial Efficiency
Ryman Healthcare’s return on equity (ROE) is -0.04 and return on invested capital (ROIC) is -0.14%.
- Return on Equity (ROE)
- -0.04
- Return on Assets (ROA)
- -0.01
- Return on Invested Capital (ROIC)
- -0.14%
- Return on Capital Employed (ROCE)
- -0.00
- Revenue Per Employee
- 102.37K
- Profits Per Employee
- -21.97K
- Employee Count
- 7,800
- Asset Turnover
- 0.07
- Inventory Turnover
- 68020.58
Valuation Ratios
The current PE Ratio of Ryman Healthcare is -10.76. Ryman Healthcare’s PEG ratio is -0.40.
- PE Ratio
- -10.76
- PS Ratio
- 2.25
- PB Ratio
- 0.44
- Price to FCF
- 6.60
- Price to Operating Cash Flow
- 5.62
- PEG Ratio
- -0.40
Income Statement
In the last 12 months, Ryman Healthcare had revenue of 798.49M and earned -171.34M in profits. Earnings per share was -0.17.
- Revenue
- 798.49M
- Gross Profit
- -17.76M
- Operating Income
- -17.76M
- Pretax Income
- -177.61M
- Net Income
- -171.34M
- EBITDA
- 24.79M
- Earnings Per Share (EPS)
- -0.17
Cash Flow
In the last 12 months, operating cash flow was 319.68M and capital expenditures -47.30M, giving a free cash flow of 272.38M billion.
- Operating Cash Flow
- 319.68M
- Free Cash Flow
- 272.38M
- Free Cash Flow per Share
- 0.27
Dividends & Yields
Ryman Healthcare pays an annual dividend of AUD 0.07, resulting in a dividend yield of ―
- Dividend Per Share
- AUD 0.07
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- 15.15%
- Earnings Yield
- -9.54%
Stock Price Statistics
- Beta
- -0.20
- 52-Week Price Change
- -41.73%
- 50-Day Moving Average
- 1.55
- 200-Day Moving Average
- 1.80
- Relative Strength Index (RSI)
- 42.57
- Average Volume (3m)
- 6,590
Important Dates
Ryman Healthcare upcoming earnings date is Nov 25, 2026, TBA (Not Confirmed).
- Last Earnings Date
- May 25, 2026
- Next Earnings Date
- Nov 25, 2026
- Ex-Dividend Date
- Dec 08, 2022
Financial Position
Ryman Healthcare as a current ratio of 0.55, with Debt / Equity ratio of 39.04%
- Current Ratio
- 0.55
- Quick Ratio
- 0.55
- Debt to Market Cap
- 0.73
- Net Debt to EBITDA
- 63.82
- Interest Coverage Ratio
- -0.15
Taxes
In the past 12 months, Ryman Healthcare has paid -6.27M in taxes.
- Income Tax
- -6.27M
- Effective Tax Rate
- 0.04
Enterprise Valuation
Ryman Healthcare EV to EBITDA ratio is 66.94, with an EV/FCF ratio of 12.41.
- EV to Sales
- 4.23
- EV to EBITDA
- 66.94
- EV to Free Cash Flow
- 12.41
- EV to Operating Cash Flow
- 10.57
Balance Sheet
Ryman Healthcare has AUD 9.70M in cash and marketable securities with AUD 1.59B in debt, giving a net cash position of -AUD 1.58B billion.
- Cash & Marketable Securities
- AUD 9.70M
- Total Debt
- AUD 1.59B
- Net Cash
- -AUD 1.58B
- Net Cash Per Share
- -AUD 1.56
- Tangible Book Value Per Share
- AUD 4.01
Margins
Gross margin is -2.22%, with operating margin of -2.22%, and net profit margin of -21.46%.
- Gross Margin
- -2.22%
- Operating Margin
- -2.22%
- Pretax Margin
- -22.24%
- Net Profit Margin
- -21.46%
- EBITDA Margin
- 6.32%
- EBIT Margin
- 0.99%
Analyst Forecast
The average price target for Ryman Healthcare is ―, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- Moderate Buy
- Analyst Count
- 1
- Revenue Growth Forecast
- 9.12%
- EPS Growth Forecast
- 73.83%
